Abstract
In this issue, Birnbaum and colleagues evaluate whether the availability of efficient adjuvant and chemotherapy treatments would have changed reductions in the risk for breast cancer death reported by randomized trials on breast cancer screening. The editorialist discusses these results and the implications for women having breast cancer screening.
| Original language | English |
|---|---|
| Pages (from-to) | 297-298 |
| Number of pages | 2 |
| Journal | Annals of Internal Medicine |
| Volume | 164 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 16 Feb 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- breast screening
- breast neoplasm screening
- breast cancer
Fingerprint
Dive into the research topics of 'Efficient treatments reduce the cost-efficiency of breast cancer screening'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver